SUPERNUS PHARMACEUTICALS, INC. Quarterly Amortization of Intangible Assets in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2011 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $19.5M, a 8.26% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $82.6M, a 176% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2021 was $30M, a 91% increase from 2020.
  • Supernus Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2020 was $15.7M, a 203% increase from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $19.5M -$1.75M -8.26% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $20.1M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $20.1M +$171K +0.86% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q3 2023 $82M $21.2M +$598K +2.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $81.4M $20.1M -$536K -2.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $82M $20M -$678K -3.28% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $82.6M $20.7M +$8.67M +72.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-09
Q3 2022 $74M $20.6M +$14.6M +244% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $59.3M $20.6M +$14.7M +247% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $44.6M $20.6M +$14.6M +244% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $30M $12M +$6.14M +104% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $23.9M $6.01M -$99K -1.62% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $24M $5.95M +$3.5M +143% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $20.4M $6.01M +$4.75M +376% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $15.7M $5.89M +$4.62M +365% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 $11.1M $6.11M +$4.8M +368% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $6.28M $2.45M +$1.14M +87.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $5.14M $1.26M -$39K -3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $5.18M $1.27M -$23K -1.78% Oct 1, 2019 Dec 31, 2019 10-K 2022-04-13
Q3 2019 $5.2M $1.31M +$6K +0.46% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $5.2M $1.31M +$6K +0.46% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-17
Q1 2019 $5.19M $1.3M $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $5.19M $1.29M -$71K -5.22% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-08
Q3 2018 $5.26M $1.3M -$2.8M -68.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $8.06M $1.3M +$300K +30% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $7.76M $1.3M +$861K +196% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $6.9M $1.36M +$903K +197% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $6M $4.1M +$3.8M +1267% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.2M $1M +$600K +150% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.6M $439K +$297K +209% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.3M $458K +$472K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $828K $300K +$200K +200% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $628K $400K +$343K +602% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $285K $142K +$85K +149% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $200K -$14K -$43K -148% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $243K $100K +$43K +75.4% Jul 1, 2015 Sep 30, 2015 10-Q 2017-01-20
Q2 2015 $200K $57K $0 0% Apr 1, 2015 Jun 30, 2015 10-Q/A 2017-01-23
Q1 2015 $200K $57K $0 0% Jan 1, 2015 Mar 31, 2015 10-Q/A 2017-01-20
Q4 2014 $200K $29K -$29K -50% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $229K $57K $0 0% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $229K $57K $0 0% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $229K $57K $0 0% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $229K $58K $0 0% Oct 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
Q3 2013 $229K $57K $0 0% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $229K $57K $0 0% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $229K $57K $0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 $229K $58K Oct 1, 2012 Dec 31, 2012 10-K 2013-03-15
Q3 2012 $57K $0 0% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $57K $0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2013-11-13
Q1 2012 $57K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $57K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $57K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.